{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/whitlow-staphylococcal-herpetic/management/staphylococcal-whitlow/","result":{"pageContext":{"chapter":{"id":"ac7fabf7-d7b7-5fb2-a0a6-1d28e040e2c8","slug":"staphylococcal-whitlow","fullItemName":"Scenario: Staphylococcal whitlow","depth":2,"htmlHeader":"<!-- begin field dd7adcf9-d2e2-47f6-a792-8e8f4d8aa0cd --><h2>Scenario: Staphylococcal whitlow</h2><!-- end field dd7adcf9-d2e2-47f6-a792-8e8f4d8aa0cd -->","summary":"Covers the management of staphylococcal whitlow, including when to prescribe antibiotics and when to incise and drain.","htmlStringContent":"<!-- begin item 2771e151-614b-4d63-b670-7b47beea7d2a --><!-- begin field 4310d41e-7b10-473c-9ecf-acbd00883a77 --><p>From age 1 month onwards.</p><!-- end field 4310d41e-7b10-473c-9ecf-acbd00883a77 --><!-- end item 2771e151-614b-4d63-b670-7b47beea7d2a -->","topic":{"id":"ac1c1826-f21a-5abd-8e92-1e2db8ea28ea","topicId":"f989f159-ab30-4d16-b9df-b534a9fd4192","topicName":"Whitlow (staphylococcal and herpetic)","slug":"whitlow-staphylococcal-herpetic","lastRevised":"Last revised in January 2021","chapters":[{"id":"8442fc1d-a788-50ac-a15a-9c2c91e8589b","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"895f3b40-8720-5843-8910-fe1b288857a8","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"7e4ec3c7-b080-5717-b1c3-0003acba46e5","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"7c70fe97-728d-5bc4-94c2-1996b37ee0f9","slug":"changes","fullItemName":"Changes"},{"id":"4889bd92-0b32-558d-8390-80d27fbcce73","slug":"update","fullItemName":"Update"}]},{"id":"1a79ca57-c8cc-5044-ac68-5d220bab1460","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"684fde23-e839-56ff-8b7f-8e6863b2c42d","slug":"goals","fullItemName":"Goals"},{"id":"97b35971-df6d-5ecb-a631-dfcf580e1fa9","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"12181a78-1b8d-58b4-884a-8930d15cf654","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"521ae353-eea7-5e2f-bd0e-b292540b72eb","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"87054726-2905-5ac0-b369-92e5fd68a177","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"2b6dffce-588f-532a-9776-7e3ff32005ee","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"2d957194-aa56-5cb7-98aa-cb3d8f988743","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"f0191f08-fb2e-5c5b-957c-8a190d5b4539","slug":"definition","fullItemName":"Definition"},{"id":"b8b2a1f1-fbc7-5b8f-a5c4-c0e9409d566f","slug":"causes","fullItemName":"Causes"},{"id":"c7287d38-e377-5d65-9c4f-3201369e0213","slug":"prevalence","fullItemName":"Prevalence"},{"id":"adc749af-b4d0-50c9-9996-b470b8f76613","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"d632b72f-6e73-58ee-9d8d-21b6101f6394","slug":"prognosis","fullItemName":"Prognosis"},{"id":"faed0075-1878-5f17-abc9-9316eaa064e7","slug":"complications","fullItemName":"Complications"}]},{"id":"96e4a200-e348-5fab-89e2-f0ba789b7b72","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"910097a7-71be-5c13-949e-0be7c045df35","slug":"diagnosis-of-whitlow","fullItemName":"Diagnosis of whitlow"},{"id":"6f468174-fafe-579c-90f9-500f22e70e17","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"8ac8a269-e748-5e7e-9b74-8fb5661d1ae5","fullItemName":"Management","slug":"management","subChapters":[{"id":"ac7fabf7-d7b7-5fb2-a0a6-1d28e040e2c8","slug":"staphylococcal-whitlow","fullItemName":"Scenario: Staphylococcal whitlow"},{"id":"bde8ed40-6fd8-505e-86bb-d75eac34743f","slug":"herpetic-whitlow","fullItemName":"Scenario: Herpetic whitlow"}]},{"id":"5d7afad5-ae43-5c2e-8ecf-6df00603ca01","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"ae3b006b-c4df-5e15-aee8-5ac6c019923f","slug":"aciclovir","fullItemName":"Aciclovir"},{"id":"46185de6-35ef-5e34-a1fd-e0d1463c538e","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"2a50e932-9f92-5a94-a8e5-aab1ee400b9d","slug":"erythromycin","fullItemName":"Erythromycin"},{"id":"0ad07f56-519a-59d6-90bc-6b6d6081e6ab","slug":"flucloxacillin","fullItemName":"Flucloxacillin"}]},{"id":"98ea0d83-9b18-58b4-aa73-7a50d72e15ba","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"4dd77db6-a4e1-5304-8a06-196e7628f612","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"0191f79d-0e03-554c-b0bd-4b592d452f4a","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"3e95c155-472c-52d0-9098-a797cec2ad27","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"f39c5716-7472-576a-be8f-7d705a0dc4dd","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"73c24405-a40a-51ba-ac01-8dd957f7c657","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"7005b3b9-63e2-5222-840e-73155dac338e","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"18dd81bb-78d7-57f1-9fc9-24aa775b3c9d","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"8ac8a269-e748-5e7e-9b74-8fb5661d1ae5","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"64893778-7aa1-52c2-93ef-367ad286e369","slug":"management-of-staphylococcal-whitlow","fullItemName":"Management of staphylococcal whitlow","depth":3,"htmlHeader":"<!-- begin field 0a685bdc-3719-44b9-a630-ed69352a0d58 --><h3>How should I manage a person with staphylococcal whitlow?</h3><!-- end field 0a685bdc-3719-44b9-a630-ed69352a0d58 -->","summary":null,"htmlStringContent":"<!-- begin item 9f9144e6-edf1-4844-948a-515a801df458 --><!-- begin field 1c04236d-fb1b-43b1-b9f6-1c66fe539f18 --><ul><li><strong>Urgently admit the person to hospital </strong>if there are systemic features (for example fever, tachycardia, or signs of shock), or associated lymphadenopathy or ascending lymphangitis.</li><li><strong>Consider arranging for same-day incision and drainage</strong> for people with a whitlow that is tense (even when a frank abscess has not developed) or fluctuant (the lesion feels 'boggy', and the overlying skin has a shiny appearance). <ul><li>The decision on whether to arrange same-day incision and drainage will depend on clinical judgement, taking into account the rapidity and degree of spread; any underlying co-morbidities, such as conditions causing immunosuppression; and whether the person (or their carer) is able to follow instructions reliably regarding monitoring for complications.</li><li>Incision and drainage may be performed in primary care if the expertise and facilities are available. Otherwise refer to a surgical unit or emergency department, according to local protocols.</li></ul></li><li><strong>If incision and drainage is not indicated:</strong><ul><li>Consider prescribing a 7-day course of oral antibiotics. <ul><li>Flucloxacillin is recommended first line. </li><li>Erythromycin or clarithromycin are alternatives if the person has a true allergy to penicillin. Prescribe erythromycin if the person is pregnant or breastfeeding.</li></ul></li><li>For more information, see <a class=\"topic-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/prescribing-information/\">Prescribing information</a>.</li><li>Seek specialist advice if the person is already known to have meticillin-resistant <em>Staphylococcus aureus</em> (MRSA) infection or a swab sample grows MRSA.</li></ul></li><li><strong>Consider taking a swab</strong> from the contents of the whitlow if:<ul><li>The whitlow is recurrent.</li><li>The person is immunosuppressed or at increased risk of infection.</li><li>The whitlow has not responded to treatment within 2–3 days.</li><li>The person has a history of meticillin-resistant<em> Staphylococcus aureus</em> (MRSA) infection or contact with MRSA. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/mrsa-in-primary-care/\">MRSA in primary care</a>.</li><li>There is doubt about the diagnosis.</li></ul></li><li><strong>Consider referral for an X-ray</strong> if there is a history of injury and the possibility of a radio-opaque foreign body.</li><li><strong>Consider the need for tetanus prophylaxis.</strong></li><li><strong>Advise the person to:</strong><ul><li>Keep the finger elevated as much as possible.</li><li>Apply moist heat three to four times a day to alleviate pain and hasten draining of the pus.</li><li>Take paracetamol or ibuprofen as required for pain relief. For more information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/analgesia-mild-to-moderate-pain/\">Analgesia - mild-to-moderate pain</a> and <a class=\"topic-reference external-reference\" href=\"/topics/nsaids-prescribing-issues/\">NSAIDs - prescribing issues</a>.</li><li>Reduce the risk of recurrence by avoiding risk factors, such as injuries to the finger tips.</li><li>Seek medical advice if:<ul><li>Swelling and pain become worse, or the whitlow becomes fluctuant (incision and drainage may be necessary).</li><li>They become systemically unwell (admission for intravenous antibiotics may be necessary).</li><li>The whitlow recurs (a swab for bacterial culture may be necessary).</li></ul></li></ul></li></ul><!-- end field 1c04236d-fb1b-43b1-b9f6-1c66fe539f18 --><!-- end item 9f9144e6-edf1-4844-948a-515a801df458 -->","subChapters":[{"id":"fbdc1df7-df8a-5a2e-ab59-1d4054476161","slug":"basis-for-recommendation-c57","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 3d7bfe33-8d54-4a0e-ad3f-3cc77309864d --><h4>Basis for recommendation</h4><!-- end field 3d7bfe33-8d54-4a0e-ad3f-3cc77309864d -->","summary":null,"htmlStringContent":"<!-- begin item c579f3ed-70b5-4aca-bfa5-9769d070866c --><!-- begin field 0fc2726a-140c-478e-a42c-d4d2d8131a1b --><h5>Arranging urgent admission to hospital</h5><ul><li>This recommendation is based on expert opinion in a review article which states that the presence of lymphadenopathy or ascending lymphangitis is an indication for intravenous antibiotics. This is due to the risk of systemic infection [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">Warbrick-Smith and Smith, 2013</a>].</li></ul><h5>Same-day incision and drainage</h5><ul><li>This recommendation is based on what CKS considers to be good clinical practice. <ul><li>Expert opinion in a review article emphasizes the importance of drainage of staphylococcal whitlow being undertaken by a person experienced in the procedure due to the potential for damage to neurovascular bundles and scar complications [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">Warbrick-Smith and Smith, 2013</a>].</li></ul></li><li>Incision and drainage is recommended to prevent serious complications (such as osteomyelitis and skin necrosis) which may develop as a result of increased pressure from pus within a small, enclosed compartment [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">Rigopoulos et al, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">Patel et al, 2014</a>].  </li></ul><h5>Oral antibiotics for people with staphylococcal whitlow</h5><ul><li>The recommendation to consider antibiotic treatment for early staphylococcal whitlow is based on expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">Clark, 2003</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">McDonald et al, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">Barabas and Fleming, 2015</a>].<ul><li>Some experts state that adequate early treatment may prevent abscess formation [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">McDonald et al, 2011</a>]. However, expert opinion in another review article discussed the limitations of non-operative treatment options for a staphylococcal whitlow and their high failure rate given the potential rapid progress of the condition [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">Desai and Yao, 2010</a>].</li></ul></li></ul><h5>Choice of antibiotics</h5><ul><li>The recommendations on the choice of antibiotics are extrapolated from recommendations on the antibiotic treatment of cellulitis in the document <em>Management of infection guidance for primary care for consultation and local adaptation</em> published by Public Health England [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">PHE, 2015</a>] and expert opinion in the British National Formulary [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">BNF 71, 2016</a>] and a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">Riain, 2013</a>].<ul><li>Flucloxacillin is recommended as first-line treatment because it has a narrow spectrum of activity and is active against Gram-positive cocci, including staphylococci and beta-haemolytic streptococci [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">Riain, 2013</a>].</li><li>Erythromycin and clarithromycin are suitable alternatives to flucloxacillin in people who have a true allergy to penicillin. They are macrolide antibiotics with a broad spectrum of activity against most sensitive Gram-positive cocci (including staphylococci and streptococci) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">Riain, 2013</a>].<ul><li>Clarithromycin is generally thought to be better tolerated than erythromycin [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">Riain, 2013</a>], and also has a more convenient dosing regimen [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">BNF 71, 2016</a>].</li><li>Erythromycin is preferred for pregnant and breastfeeding women as there is more experience with its use than with clarithromycin and most studies do not suggest an association with erythromycin use in pregnancy and adverse effects on the fetus [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">UKTIS, 2012</a>]. Only small amounts of erythromycin are present in breastmilk and it is not known to be harmful [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">BNF 71, 2016</a>].</li></ul></li></ul></li></ul><h5>Considering taking a swab</h5><ul><li>These recommendations are based on the expert opinion of previous reviewers of this CKS topic, and what CKS considers to be good clinical practice.</li></ul><h5>Referral for an X-ray</h5><ul><li>This recommendation is based on expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">Warbrick-Smith and Smith, 2013</a>].</li></ul><h5>Tetanus prophylaxis</h5><ul><li>This recommendation is based on expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">Clark, 2003</a>].</li></ul><h5>Self-care advice</h5><ul><li>Self-care recommendations are pragmatic and reflect expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">Clark, 2003</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">McDonald et al, 2011</a>] and what CKS considers to be good clinical practice.<ul><li>The aim of elevation of the finger and the use of warm soaks is to relieve discomfort, localize the infection, and promote drainage [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">Clark, 2003</a>].</li><li>CKS pragmatically recommends that the person should be advised to seek medical advice if symptoms significantly worsen, to reduce the risk of complications such as osteomyelitis, skin necrosis, sinus tract formation, and septic arthritis.</li></ul></li></ul><!-- end field 0fc2726a-140c-478e-a42c-d4d2d8131a1b --><!-- end item c579f3ed-70b5-4aca-bfa5-9769d070866c -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}